Clinical Trial Update: A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating capecitabine in combination with bevacizumab and short-course chemotherapy for metastatic colorectal cancer; the trial was terminated a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-06-23